Research Achievements

Registration Approvals

Adopting a differentiated strategy, the Company focuses on the therapeutic areas of oncology, anti-infection, digestive system diseases and central nervous system disorders, and prioritizes the development of differentiated products with significant clinical value.

  • 60 +
    Registration Approvals
  • 1
    Class 1 Innovative Drugs
  • 10 +
    First Generic Drugs
Patent Applications
As of the end of 2025, KVVIT Pharmaceutical has filed 170 patent applications, including 139 invention patents and 34 PCT and overseas patent applications. A total of 67 patents have been granted, among which 38 are invention patents (including 13 overseas granted inventions).